SAGE Therapeutics To Present At The Canaccord Genuity 36th Annual Growth Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that Jeff Jonas, M.D., Chief Executive Officer of Sage, will present at the Canaccord Genuity 36th Annual Growth Conference at 1:00 PM ET on August 10, in Boston, MA.